Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8


Multidisciplinary interventions in a specialist Drug Development Unit to improve family history documentation and onward referral of patients with advanced cancer to cancer genetics services.

Moss CA, Cojocaru E, Hanwell J, Ward S, Xu W, van Zyl M, O'Leary L, de Bono JS, Banerji U, Kaye SB, Minchom A, George AJ, Lopez J, McVeigh TP.

Eur J Cancer. 2019 Jun;114:97-106. doi: 10.1016/j.ejca.2019.04.009. Epub 2019 May 16.


A study of motivations and expectations of patients seen in phase 1 oncology clinics.

Dolly SO, Kalaitzaki E, Puglisi M, Stimpson S, Hanwell J, Fandos SS, Stapleton S, Ansari T, Peckitt C, Kaye S, Lopez J, Yap TA, van der Graaf W, de Bono J, Banerji U.

Cancer. 2016 Nov 15;122(22):3501-3508. doi: 10.1002/cncr.30235. Epub 2016 Sep 26.


A phase I study of a new nucleoside analogue, OSI-7836, using two administration schedules in patients with advanced solid malignancies.

Lee CP, de Jonge MJ, O'Donnell AE, Schothorst KL, Hanwell J, Chick JB, Brooimans RA, Adams LM, Drolet DW, de Bono JS, Kaye SB, Judson IR, Verweij J.

Clin Cancer Res. 2006 May 1;12(9):2841-8.


Effects of impaired renal function on the pharmacokinetics of raltitrexed (Tomudex ZD1694).

Judson I, Maughan T, Beale P, Primrose J, Hoskin P, Hanwell J, Berry C, Walker M, Sutcliffe F.

Br J Cancer. 1998 Nov;78(9):1188-93.


Phase I study of oral JM216 given twice daily.

Beale P, Raynaud F, Hanwell J, Berry C, Moore S, Odell D, Judson I.

Cancer Chemother Pharmacol. 1998;42(2):142-8.


Metabolism, excretion and pharmacokinetics of a single dose of [14C]-raltitrexed in cancer patients.

Beale P, Judson I, Hanwell J, Berry C, Aherne W, Hickish T, Martin P, Walker M.

Cancer Chemother Pharmacol. 1998;42(1):71-6.


Phase I trial of ZD1694, a new folate-based thymidylate synthase inhibitor, in patients with solid tumors.

Clarke SJ, Hanwell J, de Boer M, Planting A, Verweij J, Walker M, Smith R, Jackman AL, Hughes LR, Harrap KR, Kennealey GT, Judson IR.

J Clin Oncol. 1996 May;14(5):1495-503.


Supplemental Content

Loading ...
Support Center